ARTICLE | Company News

FDA warns of Zyvox interaction with psychiatric medication

July 27, 2011 12:06 AM UTC

FDA is updating the label of antibiotic Zyvox linezolid from Pfizer Inc. (NYSE:PFE) to warn about the risk of serious CNS reactions when given in combination with serotonergic psychiatric medications. The agency said the oxazolidinone antibiotic should not be given to patients receiving serotonergic drugs unless needed for conditions that may be life-threatening or require urgent treatment. ...